<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Symptomatic <z:e sem="disease" ids="C0265110" disease_type="Disease or Syndrome" abbrv="">cerebral vasospasm</z:e> (CVS) with delayed ischemic neurologic deficits affects about one third of the patients after aneurysmal <z:hpo ids='HP_0002138'>subarachnoid hemorrhage</z:hpo> (SAH) </plain></SENT>
<SENT sid="1" pm="."><plain>In spite of the lack of definite evidence of large clinical trials, the devastating outcome of the natural history of symptomatic CVS demands an aggressive CVS treatment in a practically oriented, structured multimodal treatment regimen </plain></SENT>
<SENT sid="2" pm="."><plain>With our treatment protocol good functional outcome could be reached in 66% of the patients with symptomatic CVS </plain></SENT>
<SENT sid="3" pm="."><plain>This policy requires close and fast multidisciplinary collaboration between neurosurgeons, neuroradiologists, competent in endovascular interventions, and specialists for neurointensive care </plain></SENT>
<SENT sid="4" pm="."><plain>We report on our experience with 79 cases with symptomatic CVS and delayed ischemic neurologic deficit (DIND) after aneurysmal SAH </plain></SENT>
<SENT sid="5" pm="."><plain>The different treatment options with CVS are reviewed and practical guidelines for a step by step treatment are given </plain></SENT>
</text></document>